Scott Halperin is a Canadian immunologist, professor of pediatrics, microbiology, and immunology at Dalhousie University, the head of Pediatric Infection Diseases at IWK Health Centre, and the director of the Canadian Center for Vaccinology.
Biography
Halperin received a B.Sc. from Stanford University, and an M.D. from Cornell University. He did his postdoctoral research in pediatric infectious diseases at the University of Virginia and University of Minnesota.
Career
Halperin's research focuses on pertussis and other vaccine-preventable diseases. In 2020, the Canadian Centre for Vaccinology at Dalhousie University was approved by Health Canada to begin clinical trial for a potential COVID-19 vaccine, led by Halperin. Halperin's research also focuses on public health policy in relation to the COVID-19 pandemic.
Awards
From 2004 to 2009, Halperin held the CIHR/Wyeth Pharmaceuticals clinical research chair in vaccines. He received a certificate of merit from the Canadian Paediatric Society in 2009, as well as the Max Forman Senior Research Prize from the Dalhousie Medical Research Foundation, also in 2009.
References
- "COVID‑19 researcher profile: Dr. Scott Halperin". Dalhousie News. Retrieved 17 May 2020.
- ^ "» Dr. Scott Halperin". 8 April 2013. Retrieved 17 May 2020.
- "Health Canada approves first clinical trial for potential COVID-19 vaccine". rdnewsnow.com. The Canadian Press. Retrieved 17 May 2020.
- ^ "Scott Halperin". Dalhousie University. Retrieved 17 May 2020.
- Keith Doucette (17 May 2020). "Halifax lab to do COVID-19 vaccine trials". Winnipeg Free Press. The Canadian Press. Retrieved 17 May 2020.
- Cooke, Alex (9 March 2020). "Dalhousie researchers get $1.9M to study coronavirus". CBC. Retrieved 17 May 2020.